[University Group Diabetes Program. The UGDP investigation remains clinically unacceptable].
D000328:Adult; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D010919:Placebos; D012107:Research Design; D014044:Tolbutamide / Q000009:adverse effects / Q000627:therapeutic use*
D010919:Placebos; D014044:Tolbutamide
University Group Diabetes Program. UGDP-undersøkelsen forblir klinisk uakseptabel